229 related articles for article (PubMed ID: 22458627)
21. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic thyroid cancer in young patients: a contemporary review.
Li M; Milas M; Nasr C; Brainard JA; Khan MJ; Burkey BB; Scharpf J
Am J Otolaryngol; 2013; 34(6):636-40. PubMed ID: 23993450
[TBL] [Abstract][Full Text] [Related]
23. A case of anaplastic thyroid cancer with long-term survival.
Koussis H; Maruzzo M; Scola A; Ide EC; Fassina A; Marioni G; Lora O; Corti L; Karachontziti P; Jirillo A
Anticancer Res; 2010 Apr; 30(4):1273-8. PubMed ID: 20530439
[TBL] [Abstract][Full Text] [Related]
24. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ
Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
McIver B; Hay ID; Giuffrida DF; Dvorak CE; Grant CS; Thompson GB; van Heerden JA; Goellner JR
Surgery; 2001 Dec; 130(6):1028-34. PubMed ID: 11742333
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic thyroid carcinoma: a case of a young women that reports a survival exceeding 6 years.
Batori M; Chatelou E; Straniero A; Ruggieri M
Eur Rev Med Pharmacol Sci; 2007; 11(1):69-71. PubMed ID: 17405351
[TBL] [Abstract][Full Text] [Related]
27. Disease control of differentiated thyroid carcinomas by hemithyroidectomy.
Chow TL; Choi CY; Lam SH
Singapore Med J; 2010 Apr; 51(4):311-4. PubMed ID: 20505909
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic carcinoma of the thyroid.
Hadar T; Mor C; Shvero J; Levy R; Segal K
Eur J Surg Oncol; 1993 Dec; 19(6):511-6. PubMed ID: 8270035
[TBL] [Abstract][Full Text] [Related]
29. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
30. [Surgical treatment and long-term efficacy on stage T1-3N0 differentiated thyroid carcinoma].
Li QL; Chen FJ; Zeng ZY; Guo ZM; Song M; Yang AK
Ai Zheng; 2008 Mar; 27(3):299-303. PubMed ID: 18334121
[TBL] [Abstract][Full Text] [Related]
31. Selective embolization of thyroid arteries (SETA) as a palliative treatment of inoperable anaplastic thyroid carcinoma (ATC).
Tazbir J; Dedecjus M; Kaurzel Z; Lewiński A; Brzeziński J
Neuro Endocrinol Lett; 2005 Aug; 26(4):401-6. PubMed ID: 16136001
[TBL] [Abstract][Full Text] [Related]
32. Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival.
Kazaure HS; Roman SA; Sosa JA
Cancer; 2012 Jul; 118(13):3260-7. PubMed ID: 22252610
[TBL] [Abstract][Full Text] [Related]
33. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
34. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
Are C; Shaha AR
Ann Surg Oncol; 2006 Apr; 13(4):453-64. PubMed ID: 16474910
[TBL] [Abstract][Full Text] [Related]
36. Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors.
Ito K; Hanamura T; Murayama K; Okada T; Watanabe T; Harada M; Ito T; Koyama H; Kanai T; Maeno K; Mochizuki Y; Amano J
Head Neck; 2012 Feb; 34(2):230-7. PubMed ID: 21500309
[TBL] [Abstract][Full Text] [Related]
37. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.
Chen J; Tward JD; Shrieve DC; Hitchcock YJ
Am J Clin Oncol; 2008 Oct; 31(5):460-4. PubMed ID: 18838882
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
39. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
40. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]